United Therapeutics Announces FDA Acceptance of NDA for Ralinepag in Pulmonary Arterial Hypertension, PDUFA Target Action Date June 24, 2027

MoveSurge carries market-moving headlines the moment they reach the wire, each one with what the price did next.